Seminoma laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 19: Line 19:


===Tumor Marker Tests===
===Tumor Marker Tests===
*[[tumor marker|Serum tumor marker]] tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.
*[[tumor marker|Serum tumor marker]] tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.<ref name="pmid27150447">{{cite journal |vauthors=Iwatsuki S, Naiki T, Kawai N, Etani T, Iida K, Ando R, Nagai T, Okada A, Tozawa K, Sugiyama Y, Yasui T |title=Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report |journal=J Med Case Rep |volume=10 |issue=1 |pages=114 |date=May 2016 |pmid=27150447 |pmc=4858825 |doi=10.1186/s13256-016-0906-7 |url=}}</ref><ref name="pmid24198649">{{cite journal |vauthors=Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS |title=Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance |journal=Open Access J Urol |volume=4 |issue= |pages=1–8 |date=December 2011 |pmid=24198649 |pmc=3818947 |doi=10.2147/OAJU.S15063 |url=}}</ref><ref name="pmid24502963">{{cite journal |vauthors=Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH |title=Expression of human chorionic gonadotropin in testicular germ cell tumors |journal=Urol. Oncol. |volume=32 |issue=5 |pages=727–34 |date=July 2014 |pmid=24502963 |doi=10.1016/j.urolonc.2013.11.007 |url=}}</ref><ref name="pmid8653285">{{cite journal |vauthors=Koshida K, Uchibayashi T, Yamamoto H, Hirano K |title=Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma |journal=Br J Urol |volume=77 |issue=1 |pages=138–42 |date=January 1996 |pmid=8653285 |doi= |url=}}</ref>
:*Classical or pure seminoma do not cause an elevated [[AFP|serum alpha fetoprotein]].
:*Classical or pure seminoma do not cause an elevated [[AFP|serum alpha fetoprotein]].
:*[[LDH|Lactate dehydrogenase (LDH)]] may be the only marker that is elevated in some seminomas. The degree of [[elevation]] in the [[serum]] [[LDH]] has [[prognostic]] value in advanced seminoma. High [[LDH]] levels can indicate that the [[tumor]] is large, there is a large amount of [[cancer]] in the [[body]], or the [[cancer]] is growing quickly. High levels can also mean that a man has advanced seminoma. [[Lactate dehydrogenase|LDH]] may also be high with some non-cancerous conditions<ref name="pmid24198649">{{cite journal |vauthors=Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS |title=Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance |journal=Open Access J Urol |volume=4 |issue= |pages=1–8 |date=December 2011 |pmid=24198649 |pmc=3818947 |doi=10.2147/OAJU.S15063 |url=}}</ref>.
:*[[LDH|Lactate dehydrogenase (LDH)]] may be the only marker that is elevated in some seminomas. The degree of [[elevation]] in the [[serum]] [[LDH]] has [[prognostic]] value in advanced seminoma. High [[LDH]] levels can indicate that the [[tumor]] is large, there is a large amount of [[cancer]] in the [[body]], or the [[cancer]] is growing quickly. High levels can also mean that a man has advanced seminoma. [[Lactate dehydrogenase|LDH]] may also be high with some non-cancerous conditions.
:*[[HCG|Human chorionic gonadotropin (hCG)]] may be elevated in some cases, but this correlates more to the presence of trophoblast cells within the [[tumor]]. [[HCG]] can also be high, if the man has liver [[disease]].<ref name="pmid24502963">{{cite journal |vauthors=Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH |title=Expression of human chorionic gonadotropin in testicular germ cell tumors |journal=Urol. Oncol. |volume=32 |issue=5 |pages=727–34 |date=July 2014 |pmid=24502963 |doi=10.1016/j.urolonc.2013.11.007 |url=}}</ref>
:*[[HCG|Human chorionic gonadotropin (hCG)]] may be elevated in some cases, but this correlates more to the presence of trophoblast cells within the [[tumor]]. [[HCG]] can also be high, if the man has liver [[disease]].
:*[[Blood test|Blood tests]] may detect the presence of [[placental alkaline phosphatase]] (PLAP) in 50% of cases. However, PLAP cannot usefully stand alone as a marker for seminoma and contributes little to follow-up, due to its rise with [[smoking]].<ref name="pmid8653285">{{cite journal |vauthors=Koshida K, Uchibayashi T, Yamamoto H, Hirano K |title=Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma |journal=Br J Urol |volume=77 |issue=1 |pages=138–42 |date=January 1996 |pmid=8653285 |doi= |url=}}</ref>
:*[[Blood test|Blood tests]] may detect the presence of [[placental alkaline phosphatase]] (PLAP) in 50% of cases. However, PLAP cannot usefully stand alone as a marker for seminoma and contributes little to follow-up, due to its rise with [[smoking]].


==References==
==References==

Revision as of 17:38, 7 May 2019

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma laboratory findings

CDC on Seminoma laboratory findings

Seminoma laboratory findings in the news

Blogs on Seminoma laboratory findings

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Laboratory findings consistent with the diagnosis of seminoma include Complete blood count (CBC), white blood cells, red blood cells, and platelets. Kidney function tests is used before and after orchiectomy. Serum tumor marker tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.Laboratory findings consistent with the diagnosis of seminoma include abnormal serum tumor marker levels (LDH, HCG). Some patients with seminoma may have elevated concentration of LDH. Among some patients with seminoma may have elevated concentration of human chorionic gonadotropin (hCG). Blood tests may detect the presence of placental alkaline phosphatase (PLAP) among 50% of patients with seminoma.

Laboratory Findings

Complete Blood Count

Complete blood count (CBC) measures the number and quality of white blood cells, red blood cells, and platelets.

Blood Chemistry Tests

Tumor Marker Tests

  • Serum tumor marker tests are generally used to check the response to cancer treatment. The following tumor markers may be measured for testicular seminoma.[1][2][3][4]

References

  1. Iwatsuki S, Naiki T, Kawai N, Etani T, Iida K, Ando R, Nagai T, Okada A, Tozawa K, Sugiyama Y, Yasui T (May 2016). "Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report". J Med Case Rep. 10 (1): 114. doi:10.1186/s13256-016-0906-7. PMC 4858825. PMID 27150447.
  2. Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS (December 2011). "Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance". Open Access J Urol. 4: 1–8. doi:10.2147/OAJU.S15063. PMC 3818947. PMID 24198649.
  3. Lempiäinen A, Sankila A, Hotakainen K, Haglund C, Blomqvist C, Stenman UH (July 2014). "Expression of human chorionic gonadotropin in testicular germ cell tumors". Urol. Oncol. 32 (5): 727–34. doi:10.1016/j.urolonc.2013.11.007. PMID 24502963.
  4. Koshida K, Uchibayashi T, Yamamoto H, Hirano K (January 1996). "Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma". Br J Urol. 77 (1): 138–42. PMID 8653285.

Template:WH Template:WS